Myotoxic effects of clenbuterol in the rat heart and soleus muscle

被引:61
作者
Burniston, JG
Ng, Y
Clark, WA
Colyer, J
Tan, LB
Goldspink, DF
机构
[1] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 2ET, Merseyside, England
[2] Univ Leeds, Dept Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, Dept Med, Leeds LS2 9JT, W Yorkshire, England
[4] Michael Reese Hosp & Med Ctr, Chicago, IL 60616 USA
关键词
anabolic adrenergic agonist; cardiomyocytes; sympathomimetic; necrosis; immunohistochemistry; beta-adrenergic antagonists;
D O I
10.1152/japplphysiol.00139.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Myocyte-specific necrosis in the heart and soleus muscle of adult male Wistar rats was investigated in response to a single subcutaneous injection of the anabolic beta(2)-adrenergic receptor agonist clenbuterol. Necrosis was immunohistochemically detected by administration of a myosin antibody 1 h before the clenbuterol challenge and quantified by using image analysis. Clenbuterol-induced myocyte necrosis occurred against a background of zero damage in control muscles. In the heart, the clenbuterol-induced necrosis was not uniform, being more abundant in the left subendocardium and peaking 2.4 mm from the apex. After position (2.4 mm from the apex), dose (5 mg clenbuterol/kg), and sampling time (12 h) were optimized, maximum cardiomyocyte necrosis was found to be 1.0 +/- 0.2%. In response to the same parameters (i.e., 5 mg of clenbuterol and sampled at 12 h), skeletal myocyte necrosis was 4.4 +/- 0.8% in the soleus. These data show significant myocyte-specific necrosis in the heart and skeletal muscle of the rat. Such irreversible damage in the heart suggests that clenbuterol may be damaging to long-term health.
引用
收藏
页码:1824 / 1832
页数:9
相关论文
共 39 条
  • [1] Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers
    Bakker, AJ
    Head, SI
    Wareham, AC
    Stephenson, DG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (06): : C1718 - C1726
  • [2] HETEROGENEOUS TRANSMURAL DISTRIBUTION OF BETA-ADRENERGIC-RECEPTOR SUBTYPES IN FAILING HUMAN HEARTS
    BEAU, SL
    TOLLEY, TK
    SAFFITZ, JE
    [J]. CIRCULATION, 1993, 88 (06) : 2501 - 2509
  • [3] ISOPROTERENOL-INDUCED MYOCARDIAL FIBROSIS IN RELATION TO MYOCYTE NECROSIS
    BENJAMIN, IJ
    JALIL, JE
    TAN, LB
    CHO, K
    WEBER, KT
    CLARK, WA
    [J]. CIRCULATION RESEARCH, 1989, 65 (03) : 657 - 670
  • [4] Pharmacological treatment of cachexia: any progress?
    Bruera, E
    [J]. SUPPORTIVE CARE IN CANCER, 1998, 6 (02) : 109 - 113
  • [5] A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats
    Chen, KJD
    Alway, SE
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2000, 89 (02) : 606 - 612
  • [6] ANABOLIC EFFECTS OF CLENBUTEROL ON SKELETAL-MUSCLE ARE MEDIATED BY BETA(2)-ADRENOCEPTOR ACTIVATION
    CHOO, JJ
    HORAN, MA
    LITTLE, RA
    ROTHWELL, NJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01): : E50 - E56
  • [7] Physiological cardiac reserve: development of a non-invasive method and first estimates in man
    Cooke, GA
    Marshall, P
    Al-Timman, JK
    Wright, DJ
    Riley, R
    Hainsworth, R
    Tan, LB
    [J]. HEART, 1998, 79 (03) : 289 - 294
  • [8] DIMASSI N, 1992, CARDIOSCIENCE, V3, P7
  • [9] The effects of the β2-agonist drug clenbuterol on taurine levels in heart and other tissues in the rat
    Doheny, MH
    Waterfield, CJ
    Timbrell, JA
    [J]. AMINO ACIDS, 1998, 15 (1-2) : 13 - 25
  • [10] DUCHANIE D, 1992, UNDERGROUND STEROID